Tropical dermatology: fungal tropical diseases.
Fungal infections are common in tropical countries and can have an important impact on public health. Lobomycosis is a common fungal infection in the tropical rain forest of South America, and paracoccidioidomycosis (South American blastomycosis) is a widespread and sometimes severe illness. Penicilliosis marneffei is an opportunistic infection of AIDS patients in southeast Asia. Chromoblastomycosis and mycetomas are causes of morbidity around the world. Sporotrichosis is a worldwide subcutaneous mycosis with a high incidence in tropical countries and is an important illness in immunocompromised patients. Rhinosporidiosis was classed as a fungal infection but is now considered a protistan parasite that belongs to the class Mesomycetozoea. It is included in this review because of its historical classification. In the past, most of these mycoses were restricted to specific geographic areas and natural reservoirs. There are, however, situations in which people from other regions come in contact with the pathogen. A common situation involves an accidental contamination of a traveler or worker who has contact with a tropical mycosis. Even minor trauma to the skin surface or inhalation of the fungal conidia can infect the patient. Thus recognition of the clinical symptoms and the dermatologic findings of the diseases, as well as the geographic distribution of the pathogens, can be critical in diagnosis of the tropical mycoses. This review discusses some of the more common tropical subcutaneous and systemic mycoses, as well as their signs, symptoms, methods of diagnosis, and therapies.


OBJECTIVE
At the completion of this learning activity, participants should be able to recognize the clinical and histologic presentations of tropical fungal diseases with cutaneous manifestations and be familiar with the appropriate therapies.
Lupi
Omar
O
Department of Medical Clinics (Dermatology), Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Tyring
Stephen K
SK
McGinnis
Michael R
MR
D000818:Animals; D001759:Blastomycosis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D002862:Chromoblastomycosis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D003881:Dermatomycoses / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D006801:Humans; D008271:Mycetoma / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D010229:Paracoccidioidomycosis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D010407:Penicillium; D012227:Rhinosporidiosis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D013174:Sporotrichosis / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D014330:Tropical Medicine